Question 1

What is IDEXX Laboratories's EV/EBITDA ratio?

Accepted Answer

IDEXX Laboratories (IDXX) EV/EBITDA ratio is 30.4× as of June 5, 2026. The ratio is calculated by dividing enterprise value by trailing twelve-month EBITDA, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the EV/EBITDA ratio calculated?

Accepted Answer

EV/EBITDA = Enterprise Value ÷ Trailing Twelve-Month (TTM) EBITDA, where Enterprise Value = Market Capitalisation + Total Debt − Cash & Short-Term Investments. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the EV/EBITDA ratio?

Accepted Answer

The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.

Question 4

What is a good EV/EBITDA ratio for IDEXX Laboratories?

Accepted Answer

Mature, cash-generative businesses commonly trade in the 8–12× EV/EBITDA range; higher-growth, asset-light companies often trade at 15–25×+. EV/EBITDA is most useful for comparing companies with different capital structures (debt levels) or tax regimes. For IDEXX Laboratories specifically, the relevant sector benchmark is the current sector median of 15.0×.

Question 5

Is IDEXX Laboratories's EV/EBITDA ratio high or low?

Accepted Answer

IDEXX Laboratories's EV/EBITDA ratio of 30.4× is below its own 5-year average of 37.1× and above the sector median of 15.0×. That places the current reading at the 13th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is IDEXX Laboratories's historical EV/EBITDA ratio range?

Accepted Answer

In the available daily series, IDEXX Laboratories (IDXX) EV/EBITDA ratio has ranged from a low of 10.0× in 2002 to a high of 68.8× in 2021. The 5-year average is 37.1× and the 5-year median is 35.3×.

Question 7

What was IDEXX Laboratories's EV/EBITDA ratio in 2025?

Accepted Answer

IDEXX Laboratories (IDXX) EV/EBITDA ratio at the end of 2025 was 36.5×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month EBITDA figure available at that date.

Question 8

Why does IDEXX Laboratories's EV/EBITDA ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (enterprise value, which tracks share price plus net debt) and the denominator (EBITDA). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$54.19B	$1.51B	36.5×	+9.4×	Dec 31, 2025
2024	$33.84B	$1.28B	27.1×	-11.3×	Dec 31, 2024
2023	$46.12B	$1.22B	38.3×	+3.6×	Dec 31, 2023
2022	$33.83B	$1.01B	34.7×	-19.9×	Dec 31, 2022
2021	$55.86B	$1.04B	54.6×	-0.0×	Dec 31, 2021
2020	$42.73B	$793.91M	54.6×	+18.2×	Dec 31, 2020
2019	$22.42B	$642.98M	36.4×	+7.0×	Dec 31, 2019
2018	$16.07B	$575.66M	29.4×	+0.6×	Dec 31, 2018
2017	$13.67B	$501.42M	28.8×	+2.7×	Dec 31, 2017
2016	$10.47B	$432.11M	26.1×	+6.0×	Dec 31, 2016
2015	$6.62B	$371.34M	20.1×	-3.8×	Dec 31, 2015
2014	$7.08B	$320.87M	23.9×	+6.3×	Dec 31, 2014
2013	$5.53B	$323.24M	17.6×	+1.6×	Dec 31, 2013
2012	$5.08B	$316.87M	16.0×	+0.9×	Dec 31, 2012
2011	$4.25B	$286.17M	15.1×	-0.7×	Dec 31, 2011
2010	$3.98B	$250.50M	15.8×	+2.0×	Dec 31, 2010
2009	$3.10B	$226.23M	13.8×	+2.7×	Dec 31, 2009
2008	$2.13B	$200.10M	11.1×	-13.2×	Dec 31, 2008
2007	$3.57B	$147.75M	24.3×	+6.8×	Dec 31, 2007
2006	$2.47B	$136.01M	17.5×	-0.2×	Dec 31, 2006
2005	$2.29B	$121.61M	17.7×	+3.0×	Dec 31, 2005
2004	$1.80B	$113.27M	14.7×	-1.7×	Dec 31, 2004
2003	$1.61B	$85.03M	16.3×	+5.3×	Dec 31, 2003
2002	$1.10B	$86.51M	11.0×	-1.1×	Dec 31, 2002
2001	$966.00M	$73.67M	12.1×	—	Dec 31, 2001


Gilead Sciences (GILD)	13.9×
Labcorp Holdings (LH)	13.6×
Amgen (AMGN)	13.6×
Charles River (CRL)	13.2×
Regeneron Pharmaceuticals (REGN)	12.9×
GE HealthCare (GEHC)	12.9×
UnitedHealth Group (UNH)	12.7×
Pfizer (PFE)	12.4×
Henry Schein (HSIC)	12.0×
Medtronic (MDT)	11.7×
AptarGroup (ATR)	11.5×
Bristol-Myers Squibb (BMY)	11.5×
Zimmer Biomet Holdings (ZBH)	11.2×
Biogen (BIIB)	10.5×
HCA Healthcare (HCA)	10.0×
Molina Healthcare (MOH)	8.8×
DaVita (DVA)	8.5×
IQVIA (IQV)	8.2×
Incyte (INCY)	7.9×
Cigna (CI)	7.8×
Elevance Health (ELV)	6.8×
Novo Nordisk (NVO)	6.5×
Solventum (SOLV)	5.8×
Universal Health Services (UHS)	5.7×
Humana (HUM)	4.5×

EV/EBITDA for IDEXX Laboratories (IDXX)

EV/EBITDA daily chart for IDEXX Laboratories (IDXX)

Historical EV/EBITDA for IDEXX Laboratories (IDXX) from 2001 to 2025

About EV/EBITDA at IDEXX Laboratories (IDXX)

IDEXX Laboratories EV/EBITDA by Year

IDEXX Laboratories EV/EBITDA 2025: 36.5×

IDEXX Laboratories EV/EBITDA 2024: 27.1×

IDEXX Laboratories EV/EBITDA 2023: 38.3×

IDEXX Laboratories EV/EBITDA 2022: 34.7×

IDEXX Laboratories EV/EBITDA 2021: 54.6×

Sector peers by EV/EBITDA — chart

Sector peers by EV/EBITDA — table

Frequently asked questions

IDEXX Laboratories (IDXX) Key Financials

EV/EBITDA daily chart for IDEXX Laboratories (IDXX)

Historical EV/EBITDA for IDEXX Laboratories (IDXX) from 2001 to 2025

About EV/EBITDA at IDEXX Laboratories (IDXX)

IDEXX Laboratories EV/EBITDA by Year

IDEXX Laboratories EV/EBITDA 2025: 36.5×

IDEXX Laboratories EV/EBITDA 2024: 27.1×

IDEXX Laboratories EV/EBITDA 2023: 38.3×

IDEXX Laboratories EV/EBITDA 2022: 34.7×

IDEXX Laboratories EV/EBITDA 2021: 54.6×

Sector peers by EV/EBITDA — chart

Sector peers by EV/EBITDA — table

Frequently asked questions

+What is IDEXX Laboratories's EV/EBITDA ratio?

+How is the EV/EBITDA ratio calculated?

+What is the EV/EBITDA ratio?

+What is a good EV/EBITDA ratio for IDEXX Laboratories?

+Is IDEXX Laboratories's EV/EBITDA ratio high or low?

+What is IDEXX Laboratories's historical EV/EBITDA ratio range?

+What was IDEXX Laboratories's EV/EBITDA ratio in 2025?

+Why does IDEXX Laboratories's EV/EBITDA ratio change over time?

IDEXX Laboratories (IDXX) Key Financials